THERALASE TECHNOLOGIES INC./ CA88337V1004 /
| 2024-05-14 4:11:54 PM | Chg. +0.005 | Volume | Bid6:03:12 PM | Ask6:03:12 PM | High | Low |
|---|---|---|---|---|---|---|
| 0.165CAD | +3.13% | 18,500 Turnover: 3,035 |
0.165Bid Size: 8,500 | 0.170Ask Size: 34,500 | 0.165 | 0.160 |
GlobeNewswire
2022-02-07
Theralase® Demonstrates Proof-of-Concept for Canadian-Made COVID-19 Vaccine
GlobeNewswire
2021-08-31
Theralase Releases Q221 Unaudited Financial Statements and Quarterly Newsletter
GlobeNewswire
2021-06-11
Theralase® Launches Seventh US-Based Clinical Study Site and Treats First Patient in the US
GlobeNewswire
2020-12-21
Life Sciences Company Investor Presentations Now Available for On-Demand Viewing
GlobeNewswire
2020-12-14
Virtual Conference for Life Sciences Companies Broadcast Live December 17th, 2020
GlobeNewswire
2017-09-13
Global Cancer Photodynamic Therapy Market & Cancer Photosensitisers Clinical Trial Report 2017-2023
